Research programme: PPAR agonists - GenfitAlternative Names: Compound 18; G 200; G120; G150; G170; GFT120
Latest Information Update: 03 Sep 2010
At a glance
- Originator Genfit
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Atherosclerosis; Diabetes mellitus; Dyslipidaemias; Hypertension; Obesity